Načítá se...
HSCT for GATA2 deficiency across the pond
In this issue of Blood, Tholouli et al describe successful in vivo T-cell–depleted allogeneic hematopoietic stem cell transplant (HSCT) in 4 patients with GATA2 deficiency using a reduced-intensity conditioning (RIC) regimen including serotherapy with alemtuzumab.(1) Three immediate questions come t...
Uloženo v:
| Vydáno v: | Blood |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Hematology
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5865236/ https://ncbi.nlm.nih.gov/pubmed/29567757 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2018-02-826461 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|